Fredun Pharmaceuticals Limited (BOM:539730)
1,786.60
-33.05 (-1.82%)
At close: Apr 15, 2026
Fredun Pharmaceuticals Market Cap
Fredun Pharmaceuticals has a market cap or net worth of 8.7 billion as of April 16, 2026. Its market cap has increased by 164.66% in one year.
Market Cap
8.70B
Enterprise Value
10.32B
Revenue
5.91B
Ranking
n/a
PE Ratio
25.38
Stock Price
1,786.60
Market Cap Chart
Since March 28, 2016, Fredun Pharmaceuticals's market cap has increased from 29.41M to 8.70B, an increase of 29,479.18%. That is a compound annual growth rate of 76.10%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 15, 2026 | 8.70B | 16.71% |
| Dec 31, 2025 | 7.45B | 115.10% |
| Dec 31, 2024 | 3.46B | -15.14% |
| Dec 29, 2023 | 4.08B | -20.69% |
| Dec 30, 2022 | 5.15B | 37.31% |
| Dec 31, 2021 | 3.75B | 116.89% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 26, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Amrutanjan Health Care | 15.53B |
| Shukra Pharmaceuticals | 14.74B |
| Venus Remedies | 14.26B |
| TTK Healthcare | 12.59B |
| Lincoln Pharmaceuticals | 11.87B |
| Fermenta Biotech | 9.47B |
| Wanbury | 9.09B |
| Bharat Parenterals | 8.41B |